COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,223 Articles (22,733 medRxiv, 8,490 bioRxiv)

Most recent first Previous |  Page 2403: Articles 24021-24030  | Next

Whether the Weather Will Help Us Weather the COVID-19 Pandemic: Using Machine Learning to Measure Twitter Users' Perceptions
Gupta, M., Bansal, A., Jain, B., Rochelle, J., Oak, A., Jalali, M. S.
10.1101/2020.07.29.20164814 — Posted: 2020-08-01
Sex-specificity of mortality risk factors among hospitalized COVID-19 patients in New York City: prospective cohort study
Jun, T., Nirenberg, S., Kovatch, P., Huang, K.-l.
10.1101/2020.07.29.20164640 — Posted: 2020-08-01
Loss expansion of SARS-CoV-2 specific immunity is a key risk factor in fatal patients with COVID-19
Zeng, Q., Huang, G., Li, Y.-z., Xu, G., Dong, S.-y., Zhong, T.-y., Chen, Z.-t., Xu, Y.
10.1101/2020.07.29.20164681 — Posted: 2020-08-01 Discussion: Onsite | Offsite
Throat wash as a source of SARS-CoV-2 RNA to monitor community spread of COVID-19.
Lopez-Lopes, G. I. S., Ahagon, C. M., Bonega, M. A., Santos, F. P. d., Santos, K. C. d. O., Cilli, A., Prado, L. S. d., Silva, D. B. B. d., Luz, N. B. d., Saraceni, C. P., Afonso, A. M. S., Timenetsky, M. d. C., Brigido, L. F. d. M.
10.1101/2020.07.29.20163998 — Posted: 2020-08-01
Long-term patient-reported symptoms of COVID-19: an analysis of social media data
Banda, J. M., Singh, G. V., Alser, O., PRIETO-ALHAMBRA, D.
10.1101/2020.07.29.20164418 — Posted: 2020-08-01
Effect and safety of combination of interferon alpha-2b and gamma or interferon alpha-2b for negativization of SARS-CoV-2 viral RNA. Preliminary results of a randomized controlled clinical trial.
Idelsis, E.-M., Jesus, P.-E., Yaquelin, D.-R., Dania, V.-B., Monica, B.-R., Lisandra, B.-R., Jesus, C.-R., Lisbeth, C. C., Ernesto, P.-C., Saily, T.-P., Claudia, M.-S., Ivan, C.-L., Julio Raul, F.-M., Hamlet, C.-R., Marisol, D.-G., Adriana, S.-M., Maura, G.-S., Sara Maria, M.-M., Marel, A.-V., Francisco, H.-B., Hugo, N.-C., Dianela, B.-G., Abrahan, B.-C., Mary Tania, V.-C., Gerardo, G.-N., Verena, M.-G., Iraldo, B.-R.
10.1101/2020.07.29.20164251 — Posted: 2020-08-01
Augmentation of anti-MDA5 antibody implies severe disease in COVID-19 patients
Liu, C., Wang, Q., Wang, Y., Wang, G., Wang, L., Chen, H., Jiao, T., Hu, C., Lei, X., Guo, L., Ren, L., Li, M., Zeng, X., Zhang, D., Cao, B., Wang, J.
10.1101/2020.07.29.20164780 — Posted: 2020-08-01
COVID-19 Recurrent Varies with Different Combinatorial Medical Treatments Determined by Machine Learning Approaches
Huang, J., Zhai, S., Ye, F., Wang, S., Zeng, M., Way, G., Madarha, V., Zhu, T., Qiu, L., Xu, Z., Ye, M., Liu, L., Cui, X., Liao, J.
10.1101/2020.07.29.20164699 — Posted: 2020-08-01
Household transmission of SARS-CoV-2: a systematic review and meta-analysis of secondary attack rate
Madewell, Z. J., Yang, Y., Longini, I. M., Halloran, M. E., Dean, N. E.
10.1101/2020.07.29.20164590 — Posted: 2020-08-01 Discussion: Offsite
Persistence of anti-SARS-CoV-2 antibodies in non-hospitalized COVID-19 convalescent health care workers
Bruni, M., Cecatiello, V., Diaz-Basabe, A., Lattanzi, G., Mileti, E., Monzani, S., Pirovano, L., Rizzelli, F., Visintin, C., Bonizzi, G., Giani, M., Lavitrano, M., Faravelli, S., Forneris, F., Caprioli, F., Pelicci, P. G., Natoli, G., Pasqualato, S., Mapelli, M., Facciotti, F.
10.1101/2020.07.30.20164368 — Posted: 2020-08-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).